| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9817bc2bc646f877d9cc00d90e391af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecc1ae769afc1f169d53f68d6a23d816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43e7333bcdcdaa3dd5d2257efd880f28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9444457d45cd90036bb780b3ad7be2fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N55-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
| filingDate |
2009-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_497d30e45a1e4778b219e2b8bf32c9ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49380013a30231666d3b48971549ec13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929af7022fac8254807321fbe8210671 |
| publicationDate |
2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9198893-B2 |
| titleOfInvention |
Combination antitumor therapy |
| abstract |
The present disclosure relates to methods of treating cancers that are responsive to antimetabolite or antimitotic anti-cancer agents. The methods involve the use of at least one anti-cancer agent selected from antimetabolite anti-cancer agents, antimitotic anti-cancer agents, and combinations thereof, and a superoxide dismutase mimetic to potentiate the therapeutic effect of the anti cancer agent(s). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3388082-A1 |
| priorityDate |
2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |